Skip to main content
Clinical Trials/NCT00919659
NCT00919659
Completed
Phase 2

Parenteral Nutrition Support for Patients With Pancreatic Cancer. A Phase II Study.

CONKO-Studiengruppe1 site in 1 country32 target enrollmentJanuary 2002

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cancer Cachexia
Sponsor
CONKO-Studiengruppe
Enrollment
32
Locations
1
Primary Endpoint
nutritional status presented by phase angle
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The purpose of this study is to determine whether the additional nutrition support is improving the nutritional status of patients suffering cancer caxechia or not.

Detailed Description

To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32 pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance analysis (BIA) as a proven tool for nutritional investigation in patients with chronic disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive pulmonary disease lung cancer and pancreatic cancer.

Registry
clinicaltrials.gov
Start Date
January 2002
End Date
May 2004
Last Updated
16 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
CONKO-Studiengruppe

Eligibility Criteria

Inclusion Criteria

  • histological proved pancreatic cancer
  • progressive cancer cachexia
  • refractive to enteral supplementation
  • informed consent

Exclusion Criteria

  • prefinal status
  • septic disease

Outcomes

Primary Outcomes

nutritional status presented by phase angle

Time Frame: 12 weeks

Secondary Outcomes

  • quantity of port infections, quantity of oedema, quantity of diarrhea(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials